Tissue distribution and residue depletion of metronidazole in rainbow trout (Oncorhynchus mykiss)

Tissue distribution and residue depletion of metronidazole (MNZ) was studied in rainbow trout (Oncorhynchus mykiss) following oral administration of MNZ in feed at the average dose of 25 mg kg^?1 body weight day^?1 for 7 days at 11 ± 2°C. The MNZ concentration in feed was 0.25% while daily feed intake was 1% of body weight. The concentrations of MNZ and its main metabolite, hydroxymetronidazole (MNZOH), in fish tissues were determined by LC-MS/MS. The drug was well distributed in tissues with maximum concentrations on day 1 post-administration. At this time, the mean MNZ concentrations in muscle, skin, kidney, liver and gill were 14 999, 20 269, 15 070, 10 102 and 16 467 µg kg^?1 respectively. MNZ was converted into MNZOH with the ratio of MNZOH:MNZ up to 7% in all fish tissues throughout the withdrawal period. This shows that MNZ itself is the main residue in rainbow trout. MNZ was detected at the level close to the decision limit (0.20 µg kg^?1) in muscle, skin and muscle with adhering skin up to 42 days, while in kidney, liver and gill it was up to 28 days post-administration. MNZOH was eliminated more rapidly from fish tissues and it was present in muscle alone up to 21 days. The elimination half-lives of MNZ and MNZOH in rainbow trout tissues were 1.83–2.53 and 1.24–2.12 days, respectively. When muscle without skin was analysed, higher MNZ and MNZOH concentrations were detected, and for a longer period of time, than in muscle with adhering skin. Thus muscle alone could be more appropriate for the effective residue control of MNZ in rainbow trout. For the same reason, it is also essential to ensure direct cooling immediately after sampling, since MNZ and its metabolite degrade in fish muscle and skin stored in non-freezing conditions.     

恩诺沙星注射液在猪体内残留消除规律研究

目的研究恩诺沙星注射液在猪体内的残留消除规律。方法本实验采用30头约50 kg重长白猪,随机分为2组,给药组25头,对照组5头。给药组用药量为每次2.5mg恩诺沙星/kg,每日1次,连用3d(1个疗程),使用1个疗程,对照组不给任何抗菌药物,与给药组同环境饲养。在最后一次给药6 h、24 h(1 d)、72 h(3 d)、120 h(5 d)、168 h(7 d)时采集肉、肝、肾、脂肪样本,经液相色谱-串联质谱法(liquid chromatography-tandem mass spectrometry, LC-MS/MS)测定组织中的恩诺沙星及其代谢物环丙沙星残留量之和,并利用WT1.4软件计算休药期。结果恩诺沙星注射液在猪肉中的休药期为3.17 d;在肾脏中的休药期为3.75 d;在肝脏中的休药期为8.18 d;在脂肪总的休药期为4.09 d。结论为保证兽药使用安全、食品安全和消费者健康,推荐恩诺沙星注射液在猪体内的休药期为9 d。     

Tissue deposition and residue depletion of melamine in fattening pigs following oral administration

The adulteration of animal feed as well as milk products with melamine has led to concerns about the ability to establish appropriate withdrawal intervals to ensure food safety. Two experiments were conducted in this study. The first was to investigate the deposition and depletion of melamine in blood and tissues of pigs exposed to adulterated feed with high doses of melamine. A total of 500 or 1000 mg kg^–1 melamine was added to the diet for fattening pigs (initial BW = ±60.24 kg). Melamine residues were detected in tissues (brain, duodenum, liver, heart, muscle and kidney) by LC-MS/MS. Dose-dependent effects were found between melamine residual concentration and its dose in feed. Five days after the withdrawal of melamine from the diets, the residue concentration in tissues fell below 2.5 mg kg^–1. In the second experiment, blood samples were taken at different time points from fattening pigs (BW = 100 kg) fed with adulterated feed with 1000 mg kg^–1 of melamine for 42 days. Results from the pharmacokinetics analysis showed that it would take 83 h for the melamine level in plasma depleting to the safe level of 50 ng ml^–1 after an expose of 1000 mg kg^–1 melamine contaminated feed for 42 days.     

Estimation of residue depletion of cyadox and its marker residue in edible tissues of pigs using physiologically based pharmacokinetic modelling

Physiologically based pharmacokinetic (PBPK) models are powerful tools to predict tissue distribution and depletion of veterinary drugs in food animals. However, most models only simulate the pharmacokinetics of the parent drug without considering their metabolites. In this study, a PBPK model was developed to simultaneously describe the depletion in pigs of the food animal antimicrobial agent cyadox (CYA), and its marker residue 1,4-bisdesoxycyadox (BDCYA). The CYA and BDCYA sub-models included blood, liver, kidney, gastrointestinal tract, muscle, fat and other organ compartments. Extent of plasma-protein binding, renal clearance and tissue-plasma partition coefficients of BDCYA were measured experimentally. The model was calibrated with the reported pharmacokinetic and residue depletion data from pigs dosed by oral gavage with CYA for five consecutive days, and then extrapolated to exposure in feed for two months. The model was validated with 14 consecutive day feed administration data. This PBPK model accurately simulated CYA and BDCYA in four edible tissues at 24–120 h after both oral exposure and 2-month feed administration. There was only slight overestimation of CYA in muscle and BDCYA in kidney at earlier time points (6–12 h) when dosed in feed. Monte Carlo analysis revealed excellent agreement between the estimated concentration distributions and observed data. The present model could be used for tissue residue monitoring of CYA and BDCYA in food animals, and provides a foundation for developing PBPK models to predict residue depletion of both parent drugs and their metabolites in food animals.     

Stability study of veterinary drugs in standard solutions for LC-MS/MS screening in food

A study on stability of veterinary drugs in standard solutions stored at ?80°C and at ?20°C was conducted over 1 year. Data were acquired on 152 individual stock standard solutions and also on 15 family mixes and 2 working standard solutions. All solutions were prepared, stored and compared 1 year later against freshly prepared ones by LC-MS/MS. A statistical analysis was performed to set the acceptability criteria, taking into account the variability of standard preparations. In individual stock standard solutions stored at ?80°C (12 months) and ?20°C (9 months), stability was demonstrated for 141 and 140 out of 152 compounds, i.e. for 92% and 93% of compounds, respectively. Drugs were even more stable when solubilised in either diluted family mixes or working standard solutions, with more than 99% and 94% of compounds found unaltered when stored at ?80°C and at ?20°C, respectively. In mixes, beta-lactams from the cephalosporin (cefadroxil and cephalexin) and penicillin (amoxicillin and ampicillin) families were found to be the least stable compounds when stored at ?20°C (6 months), necessitating storage at ?80°C to achieve a 1-year shelf life. The study also evidenced solubility issues for two sulfonamides (sulfadiazine and sulfamerazine) in methanol-based solutions. An independent stability study conducted by a second laboratory confirmed the 1-year stability of 3 family mixes—quinolones, sulfonamides and tetracyclines.     

Measurement of ampicillin residue levels in chicken eggs during and after medicated feed administration by LC-MS/MS

A simple and sensitive LC-MS/MS method was developed and validated for the determination of ampicillin (ABPC) in chicken eggs. Residues were extracted by reverse-phase solid-phase extraction. Chromatographic separation was performed using a reverse-phase column with an elution gradient. The limits of detection and quantification were 0.01 and 0.1 ng g^?1, respectively. For the 0.1–50 ng g^?1 concentration range, mean recovery and accuracy values were 93.9–98.5% and 100.2–118.0%, respectively. ABPC residue concentrations in eggs before, during and after 7 days of medicated feeding of maximum dosage (40 mg kg^?1 body weight day^?1) of ABPC were determined with the LC-MS/MS method. The maximum concentration of ABPC in eggs was 3.6 ± 1.7 ng g^?1 (mean ± SD) on the last day of the administration period. Residue concentrations of ABPC in eggs during and after ABPC administration were not over the Japanese maximum residue limit of 0.01 mg kg^?1.     

Deposition and depletion of maduramicin residues in eggs after oral administration to laying hens determined by LC-MS

The coccidiostat maduramicin has been approved as a feed additive for chickens and turkeys, although it is prohibited for use in laying hens. In the present study, laying hens were divided into three groups and fed for 14 days with medicated feed containing maduramicin, at three different concentrations: 50, 100 and 500 µg kg^?1. Eggs were collected during treatment and for 26 days after the end of feeding with medicated feed. Maduramicin residues were found exclusively in egg yolk, with the highest concentration in egg yolk of 459 µg kg^?1 for the highest dose. The maximum concentration of maduramicin in whole egg was 16.6 µg kg^?1 for the group receiving feed containing the maximum permitted level of maduramicin in feed (50 µg kg^?1). The half-life of elimination of maduramicin, calculated for post-treatment days 1–10, was 6.5 days. Twelve days after drug administration, the concentration of the maduramicin in egg yolk for Group 3 (fed with 500 µg kg^?1 maduramicin) still exceeded 20 µg kg^?1, while the concentrations for Groups 1 and 2 were 1.2 and 2.7 µg kg^?1, respectively.     

Multi-residue and multi-class determination of antibiotics in gilthead sea bream (Sparus aurata) by ultra high-performance liquid chromatography-tandem mass spectrometry

This paper describes a method for the determination of 41 antibiotics from seven different classes in gilthead sea bream (Sparus aurata) by ultra-high-performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS). Sulfonamides, trimethoprim, tetracyclines, macrolides, quinolones, penicillins and chloramphenicol were simultaneously determined. Fourteen procedures for sample treatment were tested and an extraction with acetonitrile and ethylenediaminetetra acetic acid was found to be the best option. The methodology was validated in accordance with Decision 2002/657/EC. Precision in terms of relative standard deviation (RSD) was under 17% for all compounds, and the recoveries ranged from 92% to 111%. CCα and CCβ were determined according to the maximum residue limit or the minimum required performance limit, when necessary. The validation provided evidence that the method was suitable for application in routine analysis for the detection and confirmation of antibiotics in muscle of gilthead sea bream, an important and intensively produced fish in aquaculture.     

Detection and quantification of 47 antibiotic residues in farmed European sea bass (Dicentrarchus labrax) using a multi-class and multi-residue UHPLC-MS/MS method

In the present study, a multi-class multi-residue method for the simultaneous detection and determination of antibiotics in European sea bass (Dicentrarchus labrax) was developed and validated. The method based on UHPLC-MS/MS proved to be a rapid, highly selective and sensitive tool, requiring minimum sample preparation, for screening and detection of 47 compounds from eight different classes. The validation was performed according to EU regulation 2002/657/EC, proving the method’s suitability for application in routine analysis. The method was applied to the analysis of 30 samples of farmed European sea bass purchased in different supermarkets in Portugal. Antibacterial residues were detected in 6 of the 30 analysed samples, namely enrofloxacin and oxytetracycline, in concentrations ranging from 0.1 to 12 µg kg^?1.     

Occurrence of perfluoroalkyl substances (PFASs) in various food items of animal origin collected in four European countries

This study summarises the results of the levels of 21 perfluoroalkyl substances (PFASs) in 50 selected pooled samples representing 15 food commodities with the special focus on those of animal origin, as meat, seafood, fish, milk, dairy products and hen eggs, which are commonly consumed in various European markets, e.g. Czech, Italian, Belgian and Norwegian. A new, rapid sample preparation approach based on the QuEChERS extraction procedure was applied. Ultra-performance liquid chromatography (UHPLC) coupled to tandem mass spectrometry (MS/MS) employing electrospray ionisation (ESI) in negative mode was used for the quantification of target analytes. Method quantification limits (MQLs) were in the range of 1–10 ng kg^?1 (ng l^?1) for fish, meat, hen eggs, cheese and milk, and in the range of 2.5–125 ng kg^?1 for butter. Only 16 of the group of 21 PFASs were found in at least one analysed sample. From 16 PFASs, perfluorooctane sulfonate (PFOS) was the most frequently detected analyte present in approximately 50% of samples (in the range of 0.98–2600 ng kg^?1). PFCAs with C8–C14 carbon chain were presented in approximately 20% of samples. The concentration ranges of individual compounds in the respective groups of PFASs were: 2.33–76.3 ng kg^?1 for PFSAs (without PFOS), 4.99–961 ng kg^?1 for PFCAs, 10.6–95.4 ng kg^?1 for PFPAs, and 1.61–519 ng kg^?1 for FOSA. The contamination level in the analysed food commodities decreased in the following order: seafood > pig/bovine liver >> freshwater/marine fish > hen egg > meat >> butter. When comparing the total contamination and profiles of PFASs in food commodities that originated from various sampling countries, differences were identified, and the contents decreased as follows: Belgium >> Norway, Italy > Czech Republic.     

Depletion of metronidazole in brook trout (Salvelinus fontinalis)

Metronidazole (MNZ), which is effective in the treatment of intestinal infections in fish, is also a suspected carcinogen and has been banned in numerous jurisdictions for use in any food-producing animal, including fish. Few reports have been published on the depletion of MNZ in fish. A depletion study was therefore undertaken using MNZ in feed provided to trout under controlled conditions. The water was maintained at 17.5 ± 0.9°C throughout the medication and depletion periods in the study. Following a 20-day acclimatisation period in the holding tanks, the trout (approximately 150–200 g bodyweight at the start of the study) were subjected to two separate medication and withdrawal periods: (A) 5 day medication/5 day withdrawal and (B) 5 day medication/16 day withdrawal. This simulated a potential multiple dosing in an aquaculture setting. In both medication periods, the trout were dosed with medicated feed containing 3 g MNZ kg^–1 fish. Fish were sacrificed in accordance with accepted animal care protocols and tissue samples were analysed by UPLC-MS/MS. Analyte concentrations in trout muscle ranged from a high of 27 000 ± 10 000 ng g^–1 for MNZ and 830 ± 570 ng g^–1 for MNZ-OH on day 1 of withdrawal period A to a low of 1.8 ± 2.3 ng g^–1 for MNZ and < 0.4 ng g^–1 for MNZ-OH on day 16 of withdrawal period B. The results demonstrate that when using the UPLC-MS/MS method, residues of MNZ may be detected in fish treated with MNZ after 16 days of withdrawal.     

ELISA法与LC-MS/MS法测定动物组织中克仑特罗残留

目的:比较酶联免疫法(ELISA)和液相色谱-串联质谱法(LC-MS/MS)测定动物组织中克仑特罗残留量的准确度、精密度及检测限。方法:样品经过处理后,分别采用ELISA法和LC-MS/MS法进行测定;用ELISA法对组织样品进行初筛,测出阳性样品利用LC-MS/MS法进行确证。结果:应用ELISA法测定样品猪肉样品中克仑特罗的回收率为67.0%～99.6%,批内变异系数3.4%～8.7%,批间变异系数6.1%～9.6%,灵敏度为0.025μg/L,最低检测限0.025μg/kg;LC-MS/MS检测方法回收率88.62%～111.43%,批内变异系数4.4%～7.4%,最低检测限0.5μg/kg;用ELISA法对50份猪肉和50份猪肝样品进行检测,筛选出3个阳性样品,经LC-MS/MS确证为阳性,两种方法检测结果一致。结论:ELISA法灵敏度和准确度较高,样品处理方法简单,成本低,适合组织中克仑特罗残留大规模筛查;LC-MS/MS准确度高,适合于阳性样品精确定量。     

液相色谱质谱联用测定多种兽药残留方法中标准品稳定性的挑战（网络首发、推荐阅读）

采用等时测量法对可用于食品和饲料链中兽药检测的标准品混合溶液和中间混合液进行了短期和长期稳定性研究。其中短期稳定性实验考察了混合标准曲线在–20（作为基线）、4和23 ℃（避光和不避光保存）条件下存储1、2、4和7 d的稳定性,而长期稳定性实验考察了中间混合液在–20、4、23 ℃（避光和不避光保存）和–80 ℃储存条件下2、4、8和12周的稳定性。结果表明,使用不含酸溶剂配制的混合标准曲线在4 ℃下建议储存1~2 d,中性储存条件即使在室温也可短期储存1~2 d。对于含有ß-内酰胺和头孢菌素类标准品的中间混合液在4 ℃和室温下储存超过1个月会损失近90%。对于含有青霉素V和G的混和标准品中间储备液,在–20 ℃不含酸的条件下可储存2周。其他类别的兽药标准品对长期储存条件要求较少。整体而言,兽药标准品中间混合液长期储存的最佳储存条件为–20 ℃。     

高效液相色谱-串联质谱同时测定草莓、杨梅中20 种植物生长调节剂残留

建立一种高效液相色谱-串联质谱同时测定草莓和杨梅中20 种植物生长调节剂残留的分析方法。样品经含1%乙酸的乙腈溶液提取后,以Phenomenex XB-C18（100 mm×2.1 mm,2.6 μm）为分析色谱柱,甲醇和5 mmol/L乙酸铵-0.1%乙酸缓冲溶液为流动相进行梯度洗脱,基质匹配标准溶液外标法定量。结果表明,20 种植物调节剂在各自的质量浓度范围内线性关系良好（r≥0.990 0）,草莓和杨梅中3 个添加量的回收率为70.0%～114.8%,相对标准偏差（n=5）为1.25%～11.1%,检出限在0.14～2.9 μg/kg之间。该方法操作简单、提取效果好,具有良好的灵敏度、回收率和重复性。     

Assessment of plasma concentrations of (−)-epigallocatechin gallate in mice following administration of a dose reflecting consumption of a standard green tea beverage

The plasma exposure of (−)-epigallocatechin gallate (EGCg) is typically assessed following administration of EGCg at doses equivalent to the consumption of at least 10 cups of green tea in one sitting. This study determines the plasma concentrations of EGCg in mice following administration of a dose reflecting typical consumption of one standard green tea beverage. Swiss Outbred mice were orally administered 0.76 mg/kg EGCg, and using a validated HPLC method, the C_max of un-conjugated and total EGCg was determined to be 31.5 ± 3.3 and 34.3 ± 2.0 nM, respectively (mean ± s.d., n = 3–5). The area under the plasma concentration versus time curve for un-conjugated and total EGCg was 114.3 ± 4.1 and 116.4 ± 4.1 nM·h, respectively (mean ± s.d., n = 3–5). To minimise potential ex vivo plasma degradation, a novel stabilizing solution of 20 mM ascorbic acid (AA) and 13 mM tris[2-carboxyethyl]phosphine hydrochloride (TCEP) was employed. Comparative evaluation of the efficacy of the 20 mM AA and 13 mM TCEP stabilizing solution to the commonly used stabilizing solution of 114 mM AA and 0.13 mM Na₂EDTA, indicated that the AA/TCEP solution provided significantly greater (p < 0.05) protection to EGCg than the AA/Na₂EDTA stabilizing solution. Overall, this study demonstrates that plasma concentrations of EGCg are in the low nM range following oral administration to mice at a dose reflecting the consumption of a standard green tea beverage. In addition, a novel stabilizing solution has been identified which may be useful in stabilizing plasma samples obtained from pharmacokinetic studies.